← Back to Patent Explorer
US4975445A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted cyclohexenes as central nervous system agents

Assignee: Warner Lambert Co LLC
•
Filing: 1989-12-06
•
Granted: 1990-12-04
•
Expires: 2009-12-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Substituted cyclohexenes are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.

Inventors

  • 👤 Bradley W. Caprathe
  • 👤 Juan C. Jaen
  • 👤 Sarah J. Smith
  • 👤 Lawrence D. Wise

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 09:09
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/12; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/72; C07D213/74; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61P; A61P15/00; A61P25/00; A61P25/14; A61P25/18; A61P25/24; A61P25/26; A61P43/00; A61P9/00; A61P9/12; C07D401/00; C07D401/02; C07D401/08; C07D409/00; C07D409/02; C07D409/08; C07D409/12; C07D417/00; C07D417/02; C07D417/12

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 164 words
A compound of Formula I ##STR29## wherein p1 R 1 is phenyl, phenyl substituted by one to four substituents selected from the group consisting of lower alkyl, lower alkoxy, lower thioalkoxy, halogen, and trifluoromethyl, 2-, 30, or 4-pyridinyl or 2-, 3-, or 4-pyridinyl substituted by lower alkyl, lower alkoxy, or halogen, 2-, 4-, or 5-pyrimidinyl or 2-, 4-, or 5-pyrimidinyl substituted by lower alkyl, lower alkoxy, or halogen, 2-pyrazinyl or 2-pyrazinyl substituted by lower alkyl, lower alkoxy, or halogen, 2- or 3-thienyl or 2- or 3-thienyl substituted by lower alkyl or halogen, 2- or 3-furanyl or 2- or 3-furanyl substituted by lower alkyl or halogen, 2-, 4-, or 5-thiazolyl or 2-, 4-, or 5-thiazolyl substituted by lower alkyl or halogen; m is zero or an integer from one to two; R 2 is ##STR30## wherein R 1 is as defined above; n is zero or an integer from one to four; and corresponding optical isomers thereof; or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 164 words
A compound of Formula I ##STR29## wherein p1 R 1 is phenyl, phenyl substituted by one to four substituents selected from the group consisting of lower alkyl, lower alkoxy, lower thioalkoxy, halogen, and trifluoromethyl, 2-, 30, or 4-pyridinyl or 2-, 3-, or 4-pyridinyl substituted by lower alkyl, lower alkoxy, or halogen, 2-, 4-, or 5-pyrimidinyl or 2-, 4-, or 5-pyrimidinyl substituted by lower alkyl, lower alkoxy, or halogen, 2-pyrazinyl or 2-pyrazinyl substituted by lower alkyl, lower alkoxy, or halogen, 2- or 3-thienyl or 2- or 3-thienyl substituted by lower alkyl or halogen, 2- or 3-furanyl or 2- or 3-furanyl substituted by lower alkyl or halogen, 2-, 4-, or 5-thiazolyl or 2-, 4-, or 5-thiazolyl substituted by lower alkyl or halogen; m is zero or an integer from one to two; R 2 is ##STR30## wherein R 1 is as defined above; n is zero or an integer from one to four; and corresponding optical isomers thereof; or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 63 words
A compound according to claim 1, in which R 1 is phenyl, phenyl substituted by para-lower alkyl, para lower alkoxy, para lower thioalkoxy, or para halogen, 2-, 3-, or 4-pyridinyl, 2-, or 3-furanyl, 2- or 3-thienyl, or 2-, 4-, or 5-thiazolyl; m is zero; ##STR31## wherein R 1 is as defined above; and n is zero or an integer from one to three.
Claim 4
Dependent Claim 52 words
A compound according to claim 2, in which R 1 is phenyl, phenyl substituted by para-lower alkoxy or para-halogen, 2-, 3-, or 4-pyridinyl, 2or 3-thienyl, or 2-, 4-, or 5-thiazolyl; m is zero; ##STR32## wherein R 1 is as defined above; and n is zero or an integer from one to two.
Claim 5
Dependent Claim 28 words
A compound according to claim 3 selected from the group consisting of: (±)-(2-Pyridinyl)-4-[4-(2-pyridinyl)-3-cyclohexen-1-yl]piperazine; (±)-1-(2-Pyridinyl)-4-[4-(3-pyridinyl)-3-cyclohexen-1-yl]piperazine; (±)-1-(2-Pyridinyl)-4-[4-(2-thienyl)-3-cyclohexen-1-yl]piperazine; (±)-1-(2-Pyridinyl)-4-[4-(3-thienyl)-3-cyclohexen-1-yl]piperazine; (±)-1-(4-Phenyl-3-cyclohexen-1-yl)-4-(2-pyridinyl)piperazine; (±)-1-(2-Pyridinyl)-4-[4-(2-thienyl)-3-cyclohexen-1-yl]methyl]piperazine; (±)-1-(2-Pyridinyl)-4-[[4-(2-pyridinyl)-3-cyclohexen-1-yl]methyl]piperazine; (±)-1-(2-Pyridinyl)-4-[4-phenyl-3-cyclohexen1-yl]methyl]piperazine; (±)-1-(2-Pyridinyl)-4-[2-[4-(2-thienyl)-3-cyclohexen-1-yl]ethyl]piperazine; (±)-1-[2-(4-Phenyl-3-cyclohexen-1-yl)ethyl]-4-(2-pyridinyl)piperazine; (±)-1-(2-Pyridinyl)-4-[2-[4-(2-pyridinyl)-3-cyclohexen-1-yl]ethyl]piperazine; (±)-1-[2-[4-(4-Fluorophenyl)-3-cyclohexen-1-yl]-ethyl]-4-(2-pyridinyl)piperazine; (±)-1-(2-Pyridinyl)-4-[2-[4-(2-thiazolyl)-3-cyclohexen-1-yl]ethyl]piperazine; (±)-1,2,3,6-Tetrahydro-4-phenyl-1-[2-[4-(2-thienyl)3-cyclohexen-1-yl]-ethyl]pyridine; and (±)-2-[4-(3,6-Dihydro-4-phenyl-1(2H)-pyridinyl)-1-cyclohexen-1-yl]pyridine.
Claim 6
Dependent Claim 27 words
A method of treating schizophrenia comprising administering to a host suffering therefrom a therapeutic effective amount of a compound according to claim 1 in unit dosage form.
Claim 7
Dependent Claim 36 words
A pharmaceutical composition adapted for administration as a dopaminergic, antipsychotic, antihypertensive or antidepressant agent comprising a therapeutic effective amount of a compound according to claim 1 in admixture with a pharmaceutically acceptable excipient, diluent or carrier.

References Cited (Backward Citations)

GB1311580A Cited
GB1327691A Cited
US4329353A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-12-03 1994-06-04 1994-12-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-12-03 1998-06-04 1998-12-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-12-03 2002-06-04 2002-12-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag